Wells Fargo Maintains Overweight on Constellium, Lowers Price Target to $38

Benzinga Newsdesk www.benzinga.com Negative 77.4%

Neg 77.4% Neu 0% Pos 0%

Wells Fargo analyst Timna Tanners maintains Constellium (NYSE:CSTM) with a Overweight and lowers the price target from $39 to $38.